Trump picks anti-vaccine activist as health secretary

United States President-elect Donald Trump announced his decision to nominate former Democratic presidential candidate Robert F Kennedy Jr. as his Secretary of Health and Human Services. The......

After historic 2023, ISRO is ready for packed 2024

The new year will witness two unmanned missions under the "Gaganyaan" project, deep ocean exploration project, "Samudrayaan" and many more. IMAGE: The ISRO is set to begin the new year with the......

Delta variant continues to be dominant across India: INSACOG

The Delta variant of SARS-CoV2 continues to be the dominant lineage for new cases across the country, while the other Variants of Concern (VoC) are at a lower rate and declining, the Indian......

Rediff's Wave Rider Retires!

After steering the Rediff mothership for close to 29 years, Ajit Balakrishnan, founder, chairman and CEO, did what few businessmen in this country do -- R-E-T-I-R-E. On August 2, 2024, we were......

New govt scheme to boost MSME sector

Micro, small and medium enterprises (MSMEs) in India are likely to get a shot in the arm through a scheme of the Consultancy Development Centre (CDC, an autonomous institution of the department of......

Foreign pharma firms ride R&D tax relief hope

Multinational drug companies with research interests in India may soon find the market more lucrative. The government plans to revive, and may extend to foreign companies, the income-tax exemptions......

S K Brahmachari is the new CSIR chief

Eleven months after RA Mashelkar retired from the leadership of India's apex research body, Council of Scientific and Industrial Research (CSIR), the government on Monday appointed Samir K......

Pharma policy to seek R&D watchdog

The new pharma policy proposed by Chemicals Minister Ram Vilas Paswan is likely to call for a central mechanism to oversee research and development projects in the country. The policy will also......